Editas Medicine, Inc.EDITNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank25
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-165.24M
↓ 41% vs avg
Percentile
P25
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
$-117.44M
Historical baseline
PeriodValueYoY Change
TTM$-165.24M+21.4%
2024$-210.28M-59.1%
2023$-132.18M+25.5%
2022$-177.35M-8.3%
2021$-163.80M+8.9%
2020$-179.84M-342.2%
2019$-40.67M+11.0%
2018$-45.71M-385.4%
2017$-9.42M+81.1%
2016$-49.93M-